O=C(NCCc1ccc(Cl)cc1)c1ccc(C[S+]([O-])Cc2cccc(Cl)c2)o1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?